BioAtla, Inc. (BCAB)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $1.80
- As of
Kresmion compiles this page from BCAB's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
BioAtla, Inc. (BCAB): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-11-16.
See the full BCAB dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for BCAB on one page. Preview it with sample data, then open it live with a free account.
Preview the BCAB dossierActive events for BCAB
- medium13F: new position
MILLENNIUM MANAGEMENT LLC new position in BCAB
- high13F: large increase
MILLENNIUM MANAGEMENT LLC added +262% to BCAB (2026Q1)
- mediumEarnings above estimates
Q1-2025: Beat consensus by 26.5% - EPS $-13 vs $-17.6802 estimate
- mediumEarnings above estimates
Q2-2025: Beat consensus by 7.0% - EPS $-16 vs $-17.2125 estimate
- mediumEarnings above estimates
Q3-2025: Beat consensus by 10.8% - EPS $-13.5 vs $-15.1302 estimate
FREE, NO ACCOUNT
Every event on BCAB, as it fires
You are seeing 5 of 6 events recorded on BCAB since 2026-06-15.
The five above landed across 3 days. The other 1 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, BCAB
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
Going concern statement
BCAB's 10-Q filed Nov 16, 2026 states:
Management's assessment concluded that there is substantial doubt about the Company's ability to continue as a going concern for a period of at least one year from the issuance date of these condensed consolidated financial statements.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on BCAB
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in BCAB on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on BCAB in the last 180 days.
Upstream: SEC EDGAR filings for BCAB
Kresmion, "BioAtla, Inc. (BCAB) institutional holdings and SEC filings", data as of 2026-11-16, https://kresmion.com/research/BCAB. Upstream data: SEC EDGAR filings for BCAB.
Link to this data (HTML):
<a href="https://kresmion.com/research/BCAB">BioAtla, Inc. (BCAB) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow BCAB on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to BCAB for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.